Results In this cohort study of 125,474 adults (mean [SD] age, 54.4 [13.1] years
When it comes to the latest blockbuster medications in the world of weight loss and diabetes management, two names dominate the conversation: Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Ozempic/Wegovy)
pic.twitter.com/s3YjJkglN0 The Tony Awards (@TheTonyAwards) September 30, 2024 The Ohio native made his Broadway debut in 2002 as Jimmy Smith in the musical Thoroughly Modern Millie , receiving a Tony nomination for that performance
(link to article in the comments) #GLP1s #WeightLossDrugs #EmployeeBenefits To view or add a comment, sign in 27% of employers say GLP-1 weight-loss drugs made up more than 15% of their total annual claims in 2024
In this regard, GLP-1R agonists (i.e., exenatide) improve insulin resistance suppressing pro-inflammatory phenotypes of monocytes/macrophages, and directly modulating NF-B activation and IL-1, IL-6, and TNF- expression (Budak et al., 2016
Clinical trial participants who maintained these practices lost 95% fat and only 5% muscle